Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kairalla BS, John
42  Ergebnisse:
Personensuche X
?
1

Predicting low bone density in children and young adults wi..:

Henderson MD PhD, Richard C ; Kairalla BS, John ; Abbas BS, Almas.
Developmental Medicine & Child Neurology.  46 (2004)  6 - p. 416-419 , 2004
Link: https://doi.org/10.1017/..
 
?
2

Azacitidine as epigenetic priming for chemotherapy is safe ..:

Guest, Erin M. ; Kairalla, John A. ; Devidas, Meenakshi...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
3

Minimal residual disease predicts outcomes in KMT2A‐rearran..:

Faulk, Kelly E. ; Kairalla, John A. ; Dreyer, ZoAnn E....
Pediatric Blood & Cancer.  70 (2023)  9 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
4

Outstanding outcomes with two low intensity regimens in chi..:

Schore, Reuven J. ; Angiolillo, Anne L. ; Kairalla, John A....
Leukemia.  , 2023
Link: https://doi.org/10.1038/..
 
?
5

Assessment of proxy‐reported responses as predictors of mot..:

Rodwin, Rozalyn L. ; DelRocco, Natalie J. ; Hibbitts, Emily...
Pediatric Blood & Cancer.  70 (2023)  11 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
6

KMT2A partner genes in infant acute lymphoblastic leukemia ..:

Robinson, Blaine W. ; Kairalla, John A. ; Devidas, Meenakshi...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
7

SARS‐CoV‐2 infections in patients enrolled on the Children'..:

Elgarten, Caitlin W. ; Kairalla, John A. ; Thompson, Joel C....
eJHaem.  4 (2023)  3 - p. 745-750 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Impaired neurocognitive functioning 3 months following diag..:

Hardy, Kristina K. ; Kairalla, John A. ; Gioia, Anthony R....
Pediatric Blood & Cancer.  70 (2023)  7 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
9

Correction: Outstanding outcomes with two low intensity reg..:

Schore, Reuven J. ; Angiolillo, Anne L. ; Kairalla, John A....
Leukemia.  , 2023
Link: https://doi.org/10.1038/..
 
?
10

Information fraction estimation: Strategies for a phase 3 n..:

Dang, Ha M. ; Krailo, Mark D. ; Alonzo, Todd A...
Pharmaceutical Statistics.  22 (2023)  6 - p. 1031-1045 , 2023
Link: https://doi.org/10.1002/..
 
?
11

Outstanding outcomes in infants with KMT2A-germline acute l..:

Guest, Erin M. ; Kairalla, John A. ; Hilden, Joanne M....
Haematologica.  107 (2022)  5 - p. 1205-1208 , 2022
Link: https://doi.org/10.3324/..
 
?
12

Persistence of Chemotherapy-Induced Peripheral Neuropathy D..:

Rodwin, Rozalyn L ; Kairalla, John A ; Hibbitts, Emily...
JNCI: Journal of the National Cancer Institute.  114 (2022)  8 - p. 1167-1175 , 2022
Link: https://doi.org/10.1093/..
 
?
13

Improving infectious adverse event reporting for children a..:

Elgarten, Caitlin W. ; Thompson, Joel C. ; Angiolillo, Anne...
Pediatric Blood & Cancer.  69 (2022)  11 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
14

Correction to: FLT3 inhibitor lestaurtinib plus chemotherap..:

Brown, Patrick A. ; Kairalla, John A. ; Hilden, Joanne M....
Leukemia.  35 (2021)  5 - p. 1527-1527 , 2021
Link: https://doi.org/10.1038/..
 
?
15

Adaptive functioning and academic achievement in survivors ..:

Jacola, Lisa M. ; Baran, Julie ; Noll, Robert B....
Pediatric Blood & Cancer.  68 (2021)  4 - p. , 2021
Link: https://doi.org/10.1002/..
 
1-15